You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 賽升藥業午後直線拉漲逾3% 與華大蛋白簽訂技術服務合同
格隆匯 12-24 14:16
格隆匯12月24日丨賽升藥業(300485.SZ)午後直線拉昇,現報8.62元,漲3.36%,暫成交2017萬元,最新總市值41.7億元。賽升藥業今日午間發公告稱,與參股公司華大蛋白簽訂技術服務合同,華大蛋白將為賽升藥業的兩款新藥研究提供技術服務。擬發生交易的金額為500萬元(人民幣,下同)。賽升藥業表示,本次關聯交易目的在於滿足公司經營發展所需的正常業務,符合公司生產經營和持續發展的需要,有利於發揮公司與關聯方的協同效應,促進公司發展。此外,為加速子公司瀋陽君元藥業建設,將引入外部投資者向君元藥業增資合計1500萬元。本次增資事項完成後,君元藥業註冊資本將增加至1290萬元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account